PCA3 Urine mRNA Testing for Prostate Carcinoma: Patterns of Use by Community Urologists and Assay Performance in Reference Laboratory Setting
Authors:
- Scott B. ShappellSSScott B. Shappell
- John FulmerJFJohn Fulmer
- David ArguelloDADavid Arguello
- Brian S. WrightBWBrian S. Wright
- Jonathan R. OppenheimerJOJonathan R. Oppenheimer
- Mathew J. PutziMPMathew J. Putzi
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy OutcomeJournal of Urology, 2008
- PCA3 Molecular Urine Assay for Prostate Cancer in Men Undergoing Repeat BiopsyUrology, 2007
- The Time-Resolved Fluorescence-Based PCA3 Test on Urinary Sediments after Digital Rectal Examination; a Dutch Multicenter Validation of the Diagnostic PerformanceClinical Cancer Research, 2007
- APTIMA PCA3 Molecular Urine Test: Development of a Method to Aid in the Diagnosis of Prostate CancerClinical Chemistry, 2006
- Screening for Prostate Cancer: Opportunities and ChallengesSurgical Oncology Clinics of North America, 2005
- DD3 RNA Analysis in Urine ? A New Perspective for Detecting Prostate CancerEuropean Urology, 2004
- uPM3, a new molecular urine test for the detection of prostate cancerUrology, 2004
- Screening for prostate cancer: current recommendationsUrologic Clinics of North America, 2004
- DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate CancerEuropean Urology, 2003
- NONPALPABLE STAGE T1C PROSTATE CANCER: PREDICTION OF INSIGNIFICANT DISEASE USING FREE/TOTAL PROSTATE SPECIFIC ANTIGEN LEVELS AND NEEDLE BIOPSY FINDINGSJournal of Urology, 1998